PFIZER has announced that a "significant proportion" of their $10.9billion research and development investment portfolio will go towards COVID-19-related science, including developing new vaccine technology.
Tuesday, 9 November 2021
Covid breakthrough: Pfizer makes 'significant' investment into revolutionary vaccine tech
PFIZER has announced that a "significant proportion" of their $10.9billion research and development investment portfolio will go towards COVID-19-related science, including developing new vaccine technology.
0 comments:
Post a Comment